Literature DB >> 14713104

S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells.

Berit Mathisen1, Rune I Lindstad, Janne Hansen, Sara Ann El-Gewely, Gunhild M Maelandsmo, Eivind Hovig, Oystein Fodstad, Thrina Loennechen, Jan-Olof Winberg.   

Abstract

To study the role of the metastasis associated protein S100A4, an osteosarcoma cell line (OHS) with a high level of this protein was transfected with a vector containing a ribozyme that degrades S100A4 mRNA and, as controls, OHS cells were transfected with the vector alone. We have followed up our previous investigation (Bjørnland et al. 1999) by a detailed investigation of these cell lines' synthesis of MMP and TIMP proteins at different cell densities. It is shown that the cell lines with a low S100A4 level produced a reduced amount of immunoreactive MMP-2 at cellular subconfluence, while at confluence there was no difference compared to the control cells. The cell lines with a reduced S100A4 level produced less of the activated form of MMP-2 (62-kDa) and less TIMP-1 than the corresponding control cells, independent of cell density. Isolated cell membranes from cell lines with a reduced S100A4 level contained less MT1-MMP, MMP-2 and TIMP-2 compared to the control cells. Activation of exogenously added proMMP-2 was less effective with the former membrane preparations. It appeared that the mechanism behind the S100A4 dependent activation of proMMP-2 varied with cell density, as SN50, a peptide inhibitor of NF-kappaB nuclear translocation reduced the activation of MMP-2 at low cell density, but had no effect at high cell density. Thus, one of the mechanisms by which S100A4 may exert its effect on metastasis of some tumors is by regulating the MMP-2 activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14713104     DOI: 10.1023/b:clin.0000006819.21361.03

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  60 in total

1.  Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction.

Authors:  M Grigorian; S Andresen; E Tulchinsky; M Kriajevska; C Carlberg; C Kruse; M Cohn; N Ambartsumian; A Christensen; G Selivanova; E Lukanidin
Journal:  J Biol Chem       Date:  2001-03-05       Impact factor: 5.157

2.  A fluorescent screening assay for collagenase using collagen labeled with 2-methoxy-2,4-diphenyl-3(2H)-furanone.

Authors:  R L O'Grady; A Nethery; N Hunter
Journal:  Anal Biochem       Date:  1984-08-01       Impact factor: 3.365

Review 3.  General mechanisms of metastasis.

Authors:  E C Woodhouse; R F Chuaqui; L A Liotta
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

Review 4.  Activation mechanisms of matrix metalloproteinases.

Authors:  H Nagase
Journal:  Biol Chem       Date:  1997 Mar-Apr       Impact factor: 3.915

5.  E-cadherin and metastasin (mts-1/S100A4) expression levels are inversely regulated in two tumor cell families.

Authors:  A Keirsebilck; S Bonné; E Bruyneel; P Vermassen; E Lukanidin; M Mareel; F van Roy
Journal:  Cancer Res       Date:  1998-10-15       Impact factor: 12.701

6.  Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma.

Authors:  O Fodstad; A Brøgger; O Bruland; O P Solheim; J M Nesland; A Pihl
Journal:  Int J Cancer       Date:  1986-07-15       Impact factor: 7.396

7.  TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP.

Authors:  Y P Han; T L Tuan; H Wu; M Hughes; W L Garner
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

8.  Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1.

Authors:  V Noë; B Fingleton; K Jacobs; H C Crawford; S Vermeulen; W Steelant; E Bruyneel; L M Matrisian; M Mareel
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

9.  Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells.

Authors:  A Lochter; S Galosy; J Muschler; N Freedman; Z Werb; M J Bissell
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

10.  Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin.

Authors:  K Takenaga; Y Nakamura; S Sakiyama; Y Hasegawa; K Sato; H Endo
Journal:  J Cell Biol       Date:  1994-03       Impact factor: 10.539

View more
  21 in total

1.  Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.

Authors:  Koichi Shimizu; Peter Libby; Viviane Z Rocha; Eduardo J Folco; Rica Shubiki; Nir Grabie; Sunyoung Jang; Andrew H Lichtman; Ayako Shimizu; Nancy Hogg; Daniel I Simon; Richard N Mitchell; Kevin Croce
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

2.  S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.

Authors:  Mohammad Saleem; Mee-Hyang Kweon; Jeremy James Johnson; Vaqar Mustafa Adhami; Irina Elcheva; Naghma Khan; Bilal Bin Hafeez; Kumar M R Bhat; Sami Sarfaraz; Shannon Reagan-Shaw; Vladimir S Spiegelman; Vijayasaradhi Setaluri; Hasan Mukhtar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-21       Impact factor: 11.205

3.  S100A4 mediated cell invasion and metastasis of esophageal squamous cell carcinoma via the regulation of MMP-2 and E-cadherin activity.

Authors:  Hong-Yan Zhang; Xian-Zhao Zheng; Xin-Hua Wang; Xiao-Yan Xuan; Feng Wang; Shan-Shan Li
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

4.  Stable knockdown of S100A4 suppresses cell migration and metastasis of osteosarcoma.

Authors:  Masahiko Fujiwara; Takeshi G Kashima; Akiko Kunita; Isao Kii; Daisuke Komura; Agamemnon E Grigoriadis; Akira Kudo; Hiroyuki Aburatani; Masashi Fukayama
Journal:  Tumour Biol       Date:  2011-03-01

5.  High glucose and Nepsilon-(carboxymethyl) lysine bovine serum albumin modulate release of matrix metalloproteinases in cultured human endothelial cells.

Authors:  Sedegheh Gharagozlian; Tore Henriksen; Svein Olav Kolset
Journal:  Eur J Nutr       Date:  2006-05-16       Impact factor: 5.614

6.  Butyrate reduces liver metastasis of rat colon carcinoma cells in vivo and resistance to oxidative stress in vitro.

Authors:  Xiaotong Li; Idun M Mikkelsen; Bente Mortensen; Jan-Olof Winberg; Nils-Erik Huseby
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

Review 7.  Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets.

Authors:  Elin Hadler-Olsen; Jan-Olof Winberg; Lars Uhlin-Hansen
Journal:  Tumour Biol       Date:  2013-05-17

8.  CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis.

Authors:  Qinglian Tang; Jinchang Lu; Changye Zou; Yang Shao; Yan Chen; Swami Narala; Hui Fang; Huaiyuan Xu; Jin Wang; Jingnan Shen; Rama Khokha
Journal:  Oncogene       Date:  2018-04-03       Impact factor: 9.867

9.  Clinical significance and prognostic value of S100A4 and matrix metalloproteinase-14 in patients with organ-confined bladder cancer.

Authors:  Yuji Sagara; Yasuyoshi Miyata; Takahisa Iwata; Shigeru Kanda; Tomayoshi Hayashi; Hideki Sakai; Hiroshi Kanetake
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

10.  Human epididymis protein 4 promotes P‑glycoprotein‑mediated chemoresistance in ovarian cancer cells through interactions with Annexin II.

Authors:  Qing Liu; Da-Wo Liu; Ming-Jun Zheng; Lu Deng; Hui-Min Wang; Shan Jin; Juan-Juan Liu; Ying-Ying Hao; Lian-Cheng Zhu; Bei Lin
Journal:  Mol Med Rep       Date:  2021-05-06       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.